Leta i den här bloggen

onsdag 8 april 2020

COVID-19 uuvuttaa T-solut : (Exhaustiomerkitsijät PD1 ja TIM3)

https://www.nature.com/articles/s41577-020-0304-7
Katson oheen  PubMed lähtreestä tietoa TIM3 ja PD1 geenistä , niiden proteiinista , merkityksestä ja niiden vastavaikuttajista, jos löytyy tietoa.

Fighting COVID-19 exhausts T cells

Lymphopenia is seen in severe cases of COVID-19, but the functional state of T cells in these patients is not known. Based on the retrospective study of 522 patients with COVID-19 and 40 healthy controls from Wuhan, China, this preprint study found that the age-dependent and clinical severity-dependent reduction in T cell numbers inversely correlates with serum levels of TNF, IL-6 and IL-10. The expression of T cell exhaustion markers (PD1 and TIM3) was assessed in peripheral blood cells from 14 patients with COVID-19 and 3 controls. CD8+ T cells from patients in intensive care units (ICUs) showed increased expression of PD1 compared with patients not in ICUs and healthy controls. This suggests that as disease severity progresses in patients with COVID-19, a concomitant rise in inflammatory cytokine levels may drive the depletion and exhaustion of T cell populations.

LÄHDETIETOA: TIM3 geeni https://www.ncbi.nlm.nih.gov/gene/84868
Official Symbol
HAVCR2 (5q33.3)
Official Full Name
hepatitis A virus cellular receptor
REVIEWED
Also known as
TIM3; CD366; KIM-3; SPTCL; TIMD3; Tim-3; TIMD-3; HAVcr-2
Summary
The protein encoded by this gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [provided by RefSeq, Sep 2011]
Expression
Broad expression in lymph node (RPKM 12.1), spleen (RPKM 10.5) and 23 other tissues See more
Preferred Names
hepatitis A virus cellular receptor 2
Names
T cell immunoglobulin mucin 3
T-cell immunoglobulin and mucin domain-containing protein 3
T-cell immunoglobulin mucin family member 3
T-cell immunoglobulin mucin receptor 3
T-cell membrane protein 3
kidney injury molecule-3
FEATURES: 
  (Huomaa miten ravinnosta riippuva molekyyli   Esim  N-terminaalissa  valiini, 8 leusiinia ja treoniini peräkkäin, kaikki nn essentiellejä aminohappoja, myös pari viiden essentiellin aminohapon sekvednssiä huomaan.  Useita   cysteiineja. Katson miten kide järjestyy ja se koordinoituu Kalsiumjonilla.
 https://www.ncbi.nlm.nih.gov/protein/NP_116171.3
Conserved Domains (2) summary
smart00410
Location:26126
IG_like; Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
pfam07686
Location:28122
V-set; Immunoglobulin V-set domain
This domain is found in antibodies as well as neural protein P0 and CTL4 amongst others.
Molekyylijärjestyy Kalsiumjonilla: T-cell immunoglobulin and mucin domain containing protein-3 (TIM-3) is an important immune regulator. Here, we describe a novel high resolution (1.7 Å) crystal structure of the human (h)TIM-3 N-terminal variable immunoglobulin (IgV) domain with bound calcium (Ca++) that was confirmed by nuclear magnetic resonance (NMR) spectroscopy. Significant conformational differences were observed in the B-C, C'-C″ and C'-D loops of hTIM-3 compared to mouse (m)TIM-3, hTIM-1 and hTIM-4. Further, the conformation of the C-C' loop of hTIM-3 was notably different from hTIM-4. Consistent with the known metal ion-dependent binding of phosphatidylserine (PtdSer) to mTIM-3 and mTIM-4, the NMR spectral analysis and crystal structure of Ca++-bound hTIM-3 revealed that residues in the hTIM-3 F-G loop coordinate binding to Ca++. In addition, we established a novel biochemical assay to define hTIM-3 functionality as determined by binding to human carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1). These studies provide new insights useful for understanding and targeting hTIM-3.

 LÄHDETIETOA2: PD1(2q37.3), PDCD1
https://www.ncbi.nlm.nih.gov/gene/5133
PDCD1
Official Full Name
programmed cell death 1
Also known as
PD1; PD-1; CD279; SLEB2; hPD-1; hPD-l; hSLE1
Summary
This gene encodes a cell surface membrane protein of the immunoglobulin superfamily. This protein is expressed in pro-B-cells and is thought to play a role in their differentiation. In mice, expression of this gene is induced in the thymus when anti-CD3 antibodies are injected and large numbers of thymocytes undergo apoptosis. Mice deficient for this gene bred on a BALB/c background developed dilated cardiomyopathy and died from congestive heart failure. These studies suggest that this gene product may also be important in T cell function and contribute to the prevention of autoimmune diseases. [provided by RefSeq, Jul 2008]
Expression
Biased expression in lymph node (RPKM 8.8), spleen (RPKM 2.6) and 7 other tissues See more
Preferred Names
programmed cell death protein 1
Names
programmed cell death 1 protein
protein PD-1
systemic lupus erythematosus susceptibility 2

FEATURES:  https://www.ncbi.nlm.nih.gov/protein/NP_005009.2
(Humaan rakenteessa kothia joihin kiinnittyy:  Nivolumab (25..34)  ja Pembrolizumab (70..77)tt on maininta Ruotsinkin FASSissa: PD1-hämmarna nivolumab (Opdivo) och pembrolizumab (Keytruda) vid avancerat malignt melanom.
   CDS             1..288
                     /gene="PDCD1"
                     /gene_synonym="CD279; hPD-1; hPD-l; hSLE1; PD-1; PD1;
                     SLEB2"
                     /coded_by="NM_005018.3:57..923"
                     /db_xref="CCDS:CCDS33428.1"
                     /db_xref="GeneID:5133"
                     /db_xref="HGNC:HGNC:8760"
                     /db_xref="MIM:600244"
ORIGIN      
        1 mqipqapwpv vwavlqlgwr pgwfldspdr pwnpptfspa llvvtegdna tftcsfsnts
       61 esfvlnwyrm spsnqtdkla afpedrsqpg qdcrfrvtql pngrdfhmsv vrarrndsgt
      121 ylcgaislap kaqikeslra elrvterrae vptahpspsp rpagqfqtlv vgvvggllgs
      181 lvllvwvlav icsraargti garrtgqplk edpsavpvfs vdygeldfqw rektpeppvp
      241 cvpeqteyat ivfpsgmgts sparrgsadg prsaqplrpe dghcswpl
//
 
 
Conserved Domains (1) summary
cd16088
Location:35144
IgV_PD1; Immunoglobulin (Ig)-like domain of Programmed cell Death 1 (PD1)
Immunoglobulin (Ig)-like domain of Programmed cell Death 1 (PD1)
Programmed cell Death 1 (PD1, also known as CD279 or cluster of differentiation 279) is a cell surface receptor that is expressed on T cells and pro-B cells. The protein's structure includes an extracellular IgV domain followed by a transmembrane region and an intracellular tail. Activation of CD4+ T cells, CD8+ T cells, NKT cells, B cells, and monocytes induces PD-1 expression, immediately after which it binds two distinct ligands, PD-L1 (also known as B7-H1 or CD274) and PD-L2, also known as B7-DC. PD-1 plays an important role in down regulating the immune system by preventing the activation of T-cells, reducing autoimmunity and promoting self-tolerance. The inhibitory effect of PD-1 is accomplished by promoting apoptosis in antigen specific T-cells in lymph nodes while simultaneously reducing apoptosis in regulatory T cells. A class of drugs that target PD-1, known as the PD-1 inhibitors, activate the immune system to attack tumors and treat cancer. Comparisons between the mouse PD-1 (mPD-1) and human PD-1 (hPD-1) reveals that unlike the mPD-1 which has a conventional IgSF V-set domain, hPD-1 lacks a C" strand, and instead the C' and D strands are connected by a long and flexible loop. In addition, the BC loop is not stabilized by disulfide bonding to the F strand of the ligand binding beta sheet. These differences result in different binding affinities of human and mouse PD-1 for their ligands

Inga kommentarer:

Skicka en kommentar